cilostazol has been researched along with latrunculin b in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahouth, SW; Buddington, RK; Conoley, VG; Li, C; Manganiello, V; Naren, AP; Nelson, DJ; Penmatsa, H; Sonecha, MD; Wine, JJ; Yarlagadda, S; Yue, J; Zhang, G; Zhang, W | 1 |
1 other study(ies) available for cilostazol and latrunculin b
Article | Year |
---|---|
Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains.
Topics: Actins; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cell Membrane; Cilostazol; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Cystic Fibrosis Transmembrane Conductance Regulator; Cytoskeleton; Humans; Membrane Microdomains; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Respiratory Mucosa; Second Messenger Systems; Swine; Tetrazoles; Thiazolidines | 2010 |